Keywords: bayer, looking, roche, otc, business, following, statements

Bayer looking at Roche's OTC business

Article | 09 February 2004

Print This

Following Roche's statements that its over-the-counter business (thought to be worth $1.6-2.4 billion) could be sold, Germany's Bayer is said ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in